Ming Yang1, Elizabeth Wu2, Huiying Rao1, Fanny H Du3, Angela Xie2, Shanna Cheng2, Cassandra Rodd2, Andy Lin4, Lai Wei1, Anna S Lok5,6. 1. Hepatology Institute, Peking University People's Hospital, Peking University Health Science Center, 11 South Xizhimen St, Beijing, 100044, China. 2. Division of Gastroenterology and Hepatology, University of Michigan Health System, 1150 W Medical Center Drive, 4321 Med Sci I, Ann Arbor, MI, 48109, USA. 3. University of Michigan Medical School, 1301 Catherine Street, Ann Arbor, MI, 48109, USA. 4. The Molecular and Behavioral Neuroscience Institute, University of Michigan, 205 Zina Pitcher Pl, Ann Arbor, MI, 48109, USA. 5. Division of Gastroenterology and Hepatology, University of Michigan Health System, 1150 W Medical Center Drive, 4321 Med Sci I, Ann Arbor, MI, 48109, USA. aslok@med.umich.edu. 6. University of Michigan Health System, 1500 E Medical Center Drive, 3912 Taubman Center, SPC 5362, Ann Arbor, MI, 48109, USA. aslok@med.umich.edu.
Abstract
BACKGROUND: Chronic liver disease is a major cause of morbidity and mortality in the USA and China, but the etiology of liver disease, medical practice, and patient expectations in these two countries are different. AIMS: To compare patient knowledge about their liver disease, patient satisfaction with liver disease care, and patient medical decision-making preference in the USA and China. METHODS: Three cohorts of established adult patients with liver disease seen in liver clinics in Ann Arbor, USA, and Beijing (urban) and Hebei (rural), China, completed a survey between May and September 2014. RESULTS: A total of 990 patients (395 USA, 398 Beijing, and 197 Hebei) were analyzed. Mean liver disease knowledge score (maximum 5) in the USA, Beijing, and Hebei patients was 4.1, 3.6, and 3.0, respectively (p < 0.001). US patients had a greater preference for collaborative decision-making: 71.8 % preferred to make treatment decisions together with the doctor, while most Chinese patients (74.6 % Beijing and 84.8 % Hebei) preferred passive decision-making. Mean satisfaction score (maximum 85) in the USA was higher than in Beijing, which in turn was higher than in Hebei (78.2 vs. 66.5 vs. 60.3, p < 0.001). There was a positive correlation between liver disease knowledge score and satisfaction score (r = 0.27, p < 0.001) and with collaborative medical decision-making (r = 0.22, p < 0.001) when responses from all sites were combined. CONCLUSIONS: Liver disease knowledge and patient satisfaction were greatest in the USA, followed by Beijing and then Hebei patients. Understanding these differences and associated factors may help to improve patient outcomes.
BACKGROUND: Chronic liver disease is a major cause of morbidity and mortality in the USA and China, but the etiology of liver disease, medical practice, and patient expectations in these two countries are different. AIMS: To compare patient knowledge about their liver disease, patient satisfaction with liver disease care, and patient medical decision-making preference in the USA and China. METHODS: Three cohorts of established adult patients with liver disease seen in liver clinics in Ann Arbor, USA, and Beijing (urban) and Hebei (rural), China, completed a survey between May and September 2014. RESULTS: A total of 990 patients (395 USA, 398 Beijing, and 197 Hebei) were analyzed. Mean liver disease knowledge score (maximum 5) in the USA, Beijing, and Hebei patients was 4.1, 3.6, and 3.0, respectively (p < 0.001). US patients had a greater preference for collaborative decision-making: 71.8 % preferred to make treatment decisions together with the doctor, while most Chinese patients (74.6 % Beijing and 84.8 % Hebei) preferred passive decision-making. Mean satisfaction score (maximum 85) in the USA was higher than in Beijing, which in turn was higher than in Hebei (78.2 vs. 66.5 vs. 60.3, p < 0.001). There was a positive correlation between liver disease knowledge score and satisfaction score (r = 0.27, p < 0.001) and with collaborative medical decision-making (r = 0.22, p < 0.001) when responses from all sites were combined. CONCLUSIONS:Liver disease knowledge and patient satisfaction were greatest in the USA, followed by Beijing and then Hebei patients. Understanding these differences and associated factors may help to improve patient outcomes.
Entities:
Keywords:
Cultural differences; Healthcare delivery; Hepatitis; Knowledge gaps; Medical decision-making
Authors: Pascal Jean-Pierre; Kevin Fiscella; Karen M Freund; Jack Clark; Julie Darnell; Alan Holden; Douglas Post; Steven R Patierno; Paul C Winters Journal: Cancer Date: 2010-10-04 Impact factor: 6.860
Authors: Julie A Wright Nunes; Kenneth A Wallston; Svetlana K Eden; Ayumi K Shintani; T Alp Ikizler; Kerri L Cavanaugh Journal: Kidney Int Date: 2011-08-10 Impact factor: 10.612
Authors: Terrence L Trentman; Eric G Cornidez; Laurie L Wilshusen; Yu-Hui H Chang; David P Seamans; David M Rosenfeld; John A Freeman; James J Chien Journal: Pain Pract Date: 2012-10-24 Impact factor: 3.183
Authors: Bernard L Marini; Kylee Funk; Michael D Kraft; Jessica M Fong; Roxanne Naanos; Stephen M Stout; Deborah Wagner Journal: Patient Educ Couns Date: 2014-05-22